1-3 of 3
Ralf Georg Meyer, MD
Close
Sort by
Journal Articles

Impact of DLI after In Vivo T-Cell-Depletion: Prophylactic CD8 Depleted or Preemptive CD3pos DLI?

Lorena Eichholz, Beate Hautprock, MD, Daniela Wehler, MD, Wolfgang Herr, MD, Ralf Georg Meyer, MD, Matthias Theobald, MD, Eva Maria Wagner, MD
Journal: Blood
Blood (2016) 128 (22): 2292.
https://doi.org/10.1182/blood.V128.22.2292.2292
Published: 2016
Journal Articles

Allogeneic Stem Cell Transplantation after Conditioning with Treosulfan, Etoposide and Cyclophosphamide for Patients with Acute Lymphoblastic Leukemia (ALL) Not Eligible for TBI-Containing Regimens: A Phase II-Study on Behalf of the German ALL Study Group (GMALL) and the German Cooperative Transplant Study Group

Nicolaus Kröger, MD, Martin Bornhäuser, MD, Matthias Stelljes, Uwe Pichlmeier, Christoph Schmid, Renate Arnold, Gesine Bug, Ralf Georg Meyer, MD, Wolfgang A. Bethge, MD, Guido Kobbe, MD, Dietrich Beelen, MD
Journal: Blood
Blood (2014) 124 (21): 2461.
https://doi.org/10.1182/blood.V124.21.2461.2461
Published: 2014
Journal Articles

Sorafenib Monotherapy Is Effective In Relapsed and RefractoryFlt3-ITD Positive Acute Myeloid Leukemia, Particularly After Allogenic Stem Cell Transplantation

Stephan Metzelder, MD, Anemone Finck, MD, Martin Fey, MD, Sebastian Scholl, MD, Matthias Kröger, MD, Andreas Reiter, MD, Helmut R. Salih, MD, Katharina Götze, MD, Ralf Georg Meyer, MD, Aristoteles Giagounidis, MD, Wolfram Brugger, MD, Matthias Vöhringer, MD, Lothar Müller, MD, Linn Yeh Ching, MD, Peter Dreger, MD, PhD, Masanori Mori, MD, Nadezda Basara, MD, Kerstin Schaefer-Eckart, MD, Beate Schultheis, MD, Claudia Baldus, MD, Andreas Neubauer, MD, Andreas Burchert, MD
Journal: Blood
Blood (2010) 116 (21): 3314.
https://doi.org/10.1182/blood.V116.21.3314.3314
Published: 2010